Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Danaher Corporation (DHR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
251.80+2.49 (+1.00%)
At close: 04:04PM EDT
251.80 0.00 (0.00%)
After hours: 07:47PM EDT
Advertisement
Sign in to post a message.
  • F
    Finn
    One of the major way to being a wealthy person is to create an investment for yourself, Bitcoin is one of the best ways of making money online.
  • r
    rog
    rog2 months ago
    $DHR conversation
    anyone still buying the dip here? Seems to be pretty deep and heading deeper... Great company and will def be back to 300+, but we could see this into the low 100's if we hit recession, which is expected. Thoughts

    ReplyReplies (5)2
  • C
    Craig
    I have a hard time reading the posts that talk about the day to day reactions to this stock. Buy it and wait for the long term results. It's this simple, it's a great company with y/y results. The stock price looking at the 5 yr or 10 yr results say all that is required. DBS works. The evolution of this business is spectacular. Enough rant. enjoy.
  • B
    Bill Johnston
    Top and bottom line beats. EPS by $0.10 and rev by about $150M. As always the jury is still out until the CC but at first glance this should be enough to get the stock back to where it was a few weeks ago.......$300..........at a minimum.
  • J
    Jonas_K
    Earnings beat, like always. Can’t beat a solide businessmodel in combination with a great management. Growth will keep going
    Bullish
  • Y
    Yahsezu
    China head winds and RBC downgrade. Seems to be an over reaction but...
  • T
    TIMSI
    expired 23 calls @260+ and 8 puts @245-; rolled 3 puts @290; assigned 2 puts @300.
  • O
    Ozzie
    Seeking Alpha article out today suggests the market is selling Life Science companies due to inflation/supply chain fears. At least with DHR, I feel these concerns are overblown. Having worked for DHR, I know how well they manage their suppliers and inventory. I also see Life Science as a space that is able to withstand inflation better than most others. Looking forward to the earnings release and cc coming up.
  • D
    Darrell
    What a gift added more today and will keep adding
    Bullish
  • a
    ari
    DHR chief scientific officer rejoins board of Evelo (EVLO) probably to look at EVLO science of the microbiome. EVLO pioneering use of microbiome to treat systemic inflammation in body. In phase 2 with psoriasis medication. Could be M and A target for DHR as EVLO fell from $18 to $1.6
  • B
    Bill Johnston
    Evercore ISI Adjusts Price Target for Danaher to $325 From $330, Maintains Outperform Rating
  • J
    JAM
    This stock will travel upward and should end the year 2022 around the $320 mark. But for those that thought DHR dip was the norm should be paying attention to highs and lows. Those that panic over dips most likely should sit on the side lines because they forget the stock market is a gamble first and foremost, with a chance of gaining great earnings.
  • H
    Howie
    Brutal. Morningstar has a fair value of 200. Looks weak for the next few months.
  • M
    Martin
    Rough pick by Kramer
    Bearish
  • a
    ari
    DNHR M&A eyed at Evelo. EVLO. Carlos Guiterrez chief scientific officer of Danaher joins board of Evelo. Evelo a total wash out fell from 18 to 1.65.
  • J
    Jonas_K
    Very solid recovery the last month. This is a winner, forever and ever.
    Bullish
  • D
    Darrell
    Wow down $10 from high this morning. Perplexing
    Bullish
  • T
    TIMSI
    big swing day. sold 12 puts @240- and 6 calls @280+.
  • O
    Ozzie
    7% decline this week. Great company but frustrating stock performance. I would figure DHR would outperform the market during tough times with their strong earning growth and likely Q1 beat coming up.
  • G
    Greg
    This chart looks like it wants to beak out to 270 soon. Anyone??
Advertisement
Advertisement